Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial
NCT03638908
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
Fluoxetine
Sponsor
University of Texas Southwestern Medical Center